RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SLNO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Soleno Therapeutics Inc stock price ended at $42.85 on Wednesday, after losing 0.81%.
(Updated on Mar 27, 2024)

Sell candidate since Mar 26, 2024 Loss -0.81% PDF

The Soleno Therapeutics Inc stock price fell by -0.81% on the last day (Wednesday, 27th Mar 2024) from $43.20 to $42.85. During the last trading day the stock fluctuated 3.44% from a day low at $42.70 to a day high of $44.17. The price has fallen in 6 of the last 10 days and is down by -2.57% for this period. Volume has increased on the last day by 49 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 249 thousand shares were bought and sold for approximately $10.69 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.86% during the next 3 months and, with a 90% probability hold a price between $42.01 and $57.21 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SLNO Signals & Forecast

There are few to no technical positive signals at the moment. The Soleno Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $42.96 and $46.15. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -18.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Soleno Therapeutics Inc stock

Soleno Therapeutics Inc finds support from accumulated volume at $42.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.47 between high and low, or 3.44%. For the last week, the stock has had daily average volatility of 5.98%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SLNO) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Soleno Therapeutics Inc to open at $43.24, and during the day (based on 14 day Average True Range), to move between $40.42 and $45.28, which gives a possible trading interval of +/-$2.43 (+/-5.67%) up or down from last closing price. If Soleno Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 11.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $43.46 (1.42%) than the support at $42.20 (1.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Soleno Therapeutics Inc stock A Buy?

The Soleno Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Soleno Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.931 Sell Candidate Unchanged

Predicted Opening Price for Soleno Therapeutics Inc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$43.24 ( 0.91%) $42.85

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SLNO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.71 4.34 %
R2 44.15 3.03 %
R1 43.80 2.22 %
Current price: 42.85
Support S1 42.68 -0.400 %
S2 42.33 -1.21 %
S3 41.77 -2.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.95 4.89 %
R2 44.88 4.74 %
R1 43.46 1.42 %
Current price 42.85
Support S1 42.20 -1.52%
S2 42.13 -1.68%
S3 37.15 -13.30%

FAQ

What is the symbol for Soleno Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Soleno Therapeutics Inc is SLNO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Soleno Therapeutics Inc Stock?
The Soleno Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Soleno Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Soleno Therapeutics Inc Stock?
Soleno Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Soleno Therapeutics Inc Stock.

What's the current price of Soleno Therapeutics Inc Stock?
As of the end of day on the 2024-03-27, the price of an Soleno Therapeutics Inc (SLNO) share was $42.85.

What is the 52-week high and low for Soleno Therapeutics Inc Stock?
The 52-week high for Soleno Therapeutics Inc Stock is $53.82 and the 52-week low is $2.10.

What is the market capitalization of Soleno Therapeutics Inc Stock?
As of the 2024-03-27, the market capitalization of Soleno Therapeutics Inc is 1.402B.

When is the next earnings date for Soleno Therapeutics Inc?
The upcoming earnings date for Soleno Therapeutics Inc is May 14, 2024.
Click to get the best stock tips daily for free!

About Soleno Therapeutics Inc

Soleno Therapeutics Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its n... SLNO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT